Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample  Marie Eckerström,

Slides:



Advertisements
Similar presentations
Alzheimer’s Disease  Goals  To understand what dementia is  To explore causes, risk factors, symptoms, and treatments of Alzheimer’s Disease  To better.
Advertisements

Cognitive Development Dementia. Stages: Preclinical First sign: memory loss for the familiar First sign: memory loss for the familiar Biological changes.
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Sleep disruption changes across the disease trajectory: Pilot findings from the healthy patterns sleep study Nancy A. Hodgson, Albert J. Safi Alzheimer's.
Update on lichen planus and its clinical variants Gillian Weston, MSIII, Michael Payette, MD, MBA International Journal of Women's Dermatology Volume 1,
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Survey on computer aided decision support for diagnosis of celiac disease Sebastian Hegenbart, Andreas Uhl, Andreas Vécsei Computers in Biology and Medicine.
Middle age self-report risk score predicts cognitive functioning and dementia in 20– 40 years  Eero Vuoksimaa, Juha O. Rinne, Noora Lindgren, Kauko Heikkilä,
DIAGNOSTIC ACCURACY AND CONFIDENCE IN THE CLINICAL DETECTION OF COGNITIVE IMPAIRMENT IN EARLY-STAGE PARKINSON’S DISEASE  Kathryn A. Wyman-Chick, Phillip.
Volume 1, Issue 1, Pages (June 2015)
Volume 3, Issue 4, Pages (November 2017)
Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer’s disease study  Wesley.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 3, Issue 1, Pages 1-9 (January 2017)
Different pathways to Alzheimer’s disease
Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer's disease  Valérie.
The differential diagnosis of amnestic mild cognitive impairment and Alzheimer's disease dementia by hippocampal volume measurement with MR in a chinese.
Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design  Arno de Wilde, Ingrid S. van Maurik, Marleen Kunneman, Femke Bouwman, Marissa.
Joana R. Guedes, Isabel Santana, Catarina Cunha, Diana Duro, Maria R
Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire  Roos J.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Volume 3, Issue 2, Pages (June 2017)
Volume 5, Pages (December 2016)
Multidimensional assessment of challenging behaviors in advanced stages of dementia in nursing homes—The insideDEM framework  Stefan Teipel, Christina.
An amylin analog used as a challenge test for Alzheimer's disease
The global prevalence of dementia: A systematic review and metaanalysis  Martin Prince, Renata Bryce, Emiliano Albanese, Anders Wimo, Wagner Ribeiro, Cleusa.
A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission.
Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline  Sander C.J.
Volume 2, Issue 1, Pages (January 2016)
Volume 3, Issue 1, Pages (January 2017)
Ben Sherwood, Andrew Xiao-Hua Zhou, Sandra Weintraub, Lan Wang 
Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin  Eva Carro, Fernando Bartolomé, Félix Bermejo-Pareja,
Imaging AD Progression Amyloid Imaging Agents.
Functional limitations and health care resource utilization for individuals with cognitive impairment without dementia: Findings from a United States.
Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)
Early Dementia Distinguishing AD From MCI
Alzheimer's disease drug development pipeline: 2018
Mild Cognitive Impairment and Mild Dementia: A Clinical Perspective
Evaluation and Management of End-Stage Liver Disease in Children
R. Cantón  Clinical Microbiology and Infection 
Fusion of deep learning models of MRI scans, Mini–Mental State Examination, and logical memory test enhances diagnosis of mild cognitive impairment  Shangran.
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Unusual Case of an Upset Stomach
Appendectomy is followed by increased risk of Crohn's disease
Todd E. Golde, Lon S. Schneider, Edward H. Koo  Neuron 
Volume 152, Issue 1, (January 2013)
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
Comorbidity and confounding in end-stage renal disease
Do team processes really have an effect on clinical performance
The validity of the Memory Alteration Test and the Test Your Memory test for community- based identification of amnestic mild cognitive impairment  Seline.
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
Volume 17, Issue 2, Pages (February 1950)
Table of contents The Journal for Nurse Practitioners
Volume 49, Issue 1, Pages v-vi (January 2018)
The atypical pneumonias: clinical diagnosis and importance
Evaluation of diagnostic tests
Abstracts Clinical Microbiology and Infection
Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective  Matthew Baumgart, Heather M. Snyder,
Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision.
Comparison of visual and quantitative florbetapir-PET reads in subjects with early Alzheimer's disease for assessing amyloid burden  Bradley Wyman, Yahong.
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients  Eric R. Siemers, Karen L. Sundell, Christopher Carlson, Michael Case,
GREY MATTER CONNECTIVITY IS ASSOCIATED WITH CLINICAL PROGRESSION IN NON-DEMENTED, AMYLOID POSITIVE PATIENTS  Betty M. Tijms, Mara ten Kate, Sander C.J.
Different pathways to Alzheimer’s disease
News & Notes Journal of Allergy and Clinical Immunology
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER.
Fig. 1. ROC curve for K-IADL to diagnose dementia or MCI
Volume 148, Issue 1, (January 2012)
Box plot showing the distribution of the TYM-MCI score for patients with SMC and aMCI/AD. aMCI/AD, amnestic mild cognitive impairment or Alzheimer’s disease;
Presentation transcript:

Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample  Marie Eckerström, Mattias Göthlin, Sindre Rolstad, Erik Hessen, Carl Eckerström, Arto Nordlund, Boo Johansson, Johan Svensson, Michael Jonsson, Simona Sacuiu, Anders Wallin  Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring  Volume 8, Pages 96-107 (January 2017) DOI: 10.1016/j.dadm.2017.04.006 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 Operationalization of SCD and NIA-AA stage subclassifications. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2017 8, 96-107DOI: (10.1016/j.dadm.2017.04.006) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 Cognitive outcome at follow-up for the subclassification groups. Abbreviations: MCI, mild cognitive impairment; NIA-AA, National Institute on Aging–Alzheimer's Association; SCD, subjective cognitive decline. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2017 8, 96-107DOI: (10.1016/j.dadm.2017.04.006) Copyright © 2017 The Authors Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.